U.S., Oct. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07866521) titled 'Sepsis Biomarker Monitoring in Burn Patients' on Aug. 06.
Brief Summary: The goal of this clinical trial is to learn if using pancreatic stone protein (PSP) test results helps doctors find and treat sepsis earlier in adults with serious burn injuries. The study will also look at whether using PSP is safe and practical in the burn intensive care unit. The main questions it aims to answer are:
* Does seeing PSP test results help doctors start the right antibiotics sooner?
* Does using PSP reduce unnecessary antibiotic use?
* Does using PSP improve recovery and other health outcomes?
Researchers will compare two groups of patients. ...